TrialTrials2023

A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial.

Flavia L Lombardo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.